Study on relationship between bioactive molecules in plasma and prognosis of coronary disease as well as coronary revascularization

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300074223

Enrollment

Unknown

Registered

2023-08-01

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Control:None

PCI:None

CABG:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) With signed informed consent; (2) Adults at the age of more than 18, male or female;(3) Confirmed coronary atherosclerotic heart disease; (4) Patients without coronary heart disease or healthy people selected as the control group; (5) The lesion degree of surgical patients met surgery standards.

Exclusion criteria

Exclusion criteria: (1) Without signed informed consent; (2) Emergency surgery; (3) Patients with contraindications to coronary revascularization; (4) Other situations deemed unsuitable for inclusion by the researcher.

Design outcomes

Primary

Measure	Time frame
CTRPs;	—

Secondary

Measure	Time frame
Chemerin;Adiponectin;	—

Countries

China

Contacts

Public ContactWei Yi

Xijing Hospital of Air Force Military Medical University

yiwei@fmmu.edu.cn+86 136 0912 6556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026